After 11 children died in the district, the administration has taken strong action. On Saturday night, police registered an FIR against Dr. Praveen Soni and Shresan Pharmaceutical Company from Kanchipuram, Tamil Nadu, at Parasia police station. Later that night, Dr. Praveen Soni was arrested by the SP’s special team near Rajpal Chowk in the Kotwali police station area of Chhindwara. This action has been taken on the complaint of BMO Dr. Ankit Sallam from the Health Department. Under the sections in which the case has been registered, there is a provision for punishment ranging from 10 years to life imprisonment. Meanwhile, the government report of Madhya Pradesh has also come out regarding the death of 11 children due to kidney failure on Saturday night. It has confirmed 46.2% Diethylene Glycol (DEG) in the syrup Coldrif. Whereas, the reports of two other syrups, Nextro-DS and Meftol P syrup, have come out ‘OK’. Medicines contained adulterated and dangerous elements It is to be noted that syrups from Shresan Pharmaceutical Company were given to children during treatment. After which, the children’s condition started deteriorating. So far, 11 children have died due to kidney failure. The administration and health department had started an investigation into this entire matter. In the preliminary investigation, it was revealed that the medicine given to the children was adulterated and contained harmful elements. Based on this, action has now been taken against both the doctor who prescribed the medicine and the pharmaceutical company. Impact of Dainik Bhaskar app’s news.. Case registered under these sections Considering the seriousness of the case, the police have intensified the investigation against the doctor and the company. According to preliminary evidence, samples of the medicine used in the treatment of children were sent for testing. The report found the medicine to be adulterated. The FIR has been registered based on the report. BMO Dr. Ankit Sallam said that The health department is taking this entire matter very seriously. Investigations are underway at both scientific and medical levels to bring out the truth behind the children’s deaths. If negligence on anyone else’s part comes to light, strict action will be taken against them as well. Meanwhile, the district administration has issued instructions to all government and private hospitals in the district to immediately stop the use of suspicious medicines. Along with this, an inspection of medicine stock has also been started. This was found in the government report of Madhya Pradesh.. The Madhya Pradesh government report regarding the death of 11 children due to kidney failure in Chhindwara district came out on Saturday night. It confirmed 46.2% Diethylene Glycol (DEG) in syrup Coldrif (Coldrif). Whereas, the report from Tamil Nadu had confirmed 48.6% DEG in Coldrif syrup. Meanwhile, the reports for two other syrups, Nextro-DS (Nextro-DS) and Meftol P syrup, have come out ‘OK’. Both of these have been declared standard quality cough syrups. It is to be noted that a total of 19 drug samples were taken. Out of which, reports for 12 have come out so far. Meanwhile, reports for 7 drugs are still awaited. Drug Controller Dinesh Kumar Maurya said that As soon as the information was received, different agencies started examining the samples. The report from Tamil Nadu found a large amount of diethylene glycol in Coldrif syrup. Our report also confirmed this. We are in contact with the Drug Controller of Himachal Pradesh. Guideline 0.1%, but 48.6% poisonous chemical found A senior official of Madhya Pradesh FDA stated that according to the guidelines, a maximum of 0.1 percent diethylene glycol is acceptable in cough syrup. However, the investigation revealed that the amount in Coldrif syrup was 48.6 percent. This is an extremely fatal and life-threatening level, which can lead to conditions like kidney failure and brain damage. Himachal Government Stopped Production Himachal Pradesh Drug Controller Manish Kapoor said that after receiving a letter from the Madhya Pradesh government, we have started an investigation. As a precautionary measure, the production of Nextro-DS syrup has been stopped. Samples of the batches supplied to Madhya Pradesh have been tested. Along with this, the supply chain is also being tracked, so that we can keep an eye on the stock of this syrup. The company has been asked to immediately stop sales and inform its dealers. Now, further action will be decided based on the Madhya Pradesh government’s report. Defrost Syrup Recalled from Market Instructions have been issued to recall Defrost Syrup, manufactured in Indore, from the market. The Department of Public Health and Medical Education has issued a show-cause notice against Indore’s Arc Pharmaceutical Company and instructed to recall Defrost Syrup Batch No. 11198 from the market. Additionally, the Drugs Controller General (Government of India) and the Drug Controllers of the concerned states, Himachal Pradesh and Tamil Nadu, have been asked to take necessary action by writing a letter. Coldrif and Nextro-DS cough syrup also banned in MP Earlier on Saturday, after Tamil Nadu, Coldrif and Nextro-DS cough syrups were also banned in Madhya Pradesh. Due to these syrups, 11 children died of kidney failure in Chhindwara. CM Mohan Yadav has given this information. It was revealed that children were given Coldrif and Nextro-DS cough syrups on the advice of a local doctor. After the death of the children, three teams have been formed for investigation. Now, an SIT will be formed to conduct a state-level investigation. Post navigation BJP leader held accepting ₹30,000 for threatening youth in fake-rape-case:Narsinghpur police release him later, accused had pressurized to withdraw complaint Rajasthan businessman to take ‘Muni Diksha’ in Indore today:Anil Mehta to renounce worldly life, says luxury and attachments are temporary